US Patent 11918623 GIP/GLP1 agonist compositions
Patent 11918623 was granted and assigned to Eli Lilly and Company on March, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 12 Mar, 2024
Golden AI
Edits made to:
Infobox (+19 properties)
Article (+147 characters)
US Patent 11918623 GIP/GLP1 agonist compositions
Article
Patent abstract
A composition of tirzepatide, comprising an agent selected from NaCl and propylene glycol; and dibasic sodium phosphate is provided.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Christopher Sears Minie0
Dinesh Shyamdeo Mishra0
Ken Kangyi Qian0
Vincent John Corvari0
Date of Patent
March 5, 2024
0Patent Application Number
177410670
Date Filed
May 10, 2022
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11918623 GIP/GLP1 agonist compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.